You are here

Home

Clinical Trials: Lung Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, August 23, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF
Condition:   Idiopathic Pulmonary Fibrosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Monday, August 23, 2021 - 12:00
Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells
Conditions:   Corona Virus Infection;   Covid19
Intervention:   Biological: Autologous adipose-derived stem cells
Sponsor:   Celltex Therapeutics Corporation
Not yet recruiting
Posted: Thursday, August 12, 2021 - 12:00
Investigating the Potential Role of Aerosolized All-trans Retinoic Acid for Treating COVID-19 Anosmia and Regaining Sense of Smell.
Condition:   Post COVID-19 Anosmia (Loss of Smell)
Interventions:   Drug: Aerosolized All trans retinoic acid;   Drug: Placebo/Control
Sponsors:   Amr kamel khalil Ahmed;   Faculty of Medicine, Kafrelshiekh Univversity,Egypt.
Not yet recruiting
Posted: Monday, August 9, 2021 - 12:00
Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury
Conditions:   Ischemic Heart Disease;   Lung Injury;   Non-cardiac Surgery
Interventions:   Biological: human umbilical cord-derived mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, August 5, 2021 - 12:00
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise
Condition:   Covid19
Interventions:   Biological: COVI-MSC;   Biological: Placebo
Sponsor:   Sorrento Therapeutics, Inc.
Not yet recruiting
Posted: Wednesday, July 7, 2021 - 12:00
Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research
Condition:   Acute Lung Injury
Intervention:   Biological: human derived umbilical cord derived mesenchymal stem cells
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
Posted: Friday, June 11, 2021 - 12:00
A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)
Condition:   Covid19
Interventions:   Drug: ALLOCETRA-OTS;   Other: Placebo
Sponsor:   Enlivex Therapeutics Ltd.
Not yet recruiting
Posted: Wednesday, June 9, 2021 - 12:00
Allogeneic MSC Treatment for Pulmonary Emphysema
Conditions:   Pulmonary Emphysema;   Mesenchymal Stromal Cells
Interventions:   Genetic: Allogeneic MSC;   Drug: Placebo
Sponsors:   Leiden University Medical Center;   Erasmus Medical Center;   VU University Medical Center
Recruiting
Posted: Wednesday, June 2, 2021 - 12:00
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID Acute Respiratory Distress Syndrome
Conditions:   Acute Respiratory Distress Syndrome;   Ards
Interventions:   Biological: COVI-MSC;   Drug: Placebo
Sponsor:   Sorrento Therapeutics, Inc.
Not yet recruiting
Posted: Friday, May 28, 2021 - 12:00
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress
Condition:   Covid19
Interventions:   Biological: COVI-MSC;   Drug: Placebo
Sponsor:   Sorrento Therapeutics, Inc.
Not yet recruiting

Pages